By Paul Armentano, NORML The prolonged daily administration of cannabinoids is associated with a reduction in migraine headache frequency, according to clinical trial data presented at the 3rd Congress of the European Academy of Neurology. Italian researchers compared the efficacy of oral cannabinoid treatments versus amitriptyline – an anti-depressant commonly prescribed for migraines – in 79 chronic migraine patients over …
Tag: migraines treatment
- Arkansas First Ever Medical Marijuana Dispensary Now Open
- Medical Marijuana vs. Recreational Marijuana
- How Does Medicare Cover Arthritis?
- Florida Legislature Approves Bill to Establish Agricultural Hemp Program
- Study: Most Health Professionals (Doctors, Pharmacists and Nurses) Support Medical Marijuana
- Canada: Marijuana Body Gives Recommendations to Boost Industry
- Illinois Bill Would Legalize Marijuana
- Marijuana Use Not Associated with Psychosis in Young People Finds Study
Thank you for reading TheJointBlog.com!